Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.
Takeda K, Kawasaki Y, Sakayauchi T, Takahashi C, Katagiri Y, Tanabe T, Ishikawa Y, Fujimoto K, Kubozono M, Kozumi M, Abe K, Narazaki K, Tasaka S, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Ito A, Jingu K. Takeda K, et al. Among authors: narazaki k. Asia Ocean J Nucl Med Biol. 2023;11(1):13-22. doi: 10.22038/AOJNMB.2022.67136.1468. Asia Ocean J Nucl Med Biol. 2023. PMID: 36619192 Free PMC article.
Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml.
Umezawa R, Ariga H, Ogawa Y, Jingu K, Matsushita H, Takeda K, Fujimoto K, Sakayauchi T, Sugawara T, Kubozono M, Narazaki K, Shimizu E, Takai Y, Yamada S. Umezawa R, et al. Among authors: narazaki k. Radiat Oncol. 2011 Nov 5;6:150. doi: 10.1186/1748-717X-6-150. Radiat Oncol. 2011. PMID: 22053922 Free PMC article.
Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan.
Takeda K, Takai Y, Narazaki K, Mitsuya M, Umezawa R, Kadoya N, Fujita Y, Sugawara T, Kubozono M, Shimizu E, Abe K, Shirata Y, Ishikawa Y, Yamamoto T, Kozumi M, Dobashi S, Matsushita H, Chida K, Ishidoya S, Arai Y, Jingu K, Yamada S. Takeda K, et al. Among authors: narazaki k. Radiat Oncol. 2012 Jul 6;7:105. doi: 10.1186/1748-717X-7-105. Radiat Oncol. 2012. PMID: 22770471 Free PMC article.
Temporal change in brain natriuretic Peptide after radiotherapy for thoracic esophageal cancer.
Jingu K, Nemoto K, Kaneta T, Oikawa M, Ogawa Y, Ariga H, Takeda K, Sakayauchi T, Fujimoto K, Narazaki K, Takai Y, Nakata E, Fukuda H, Takahashi S, Yamada S. Jingu K, et al. Among authors: narazaki k. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1417-23. doi: 10.1016/j.ijrobp.2007.05.054. Epub 2007 Sep 14. Int J Radiat Oncol Biol Phys. 2007. PMID: 17869015
Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.
Jingu K, Ariga H, Kaneta T, Takai Y, Takeda K, Katja L, Narazaki K, Metoki T, Fujimoto K, Umezawa R, Ogawa Y, Nemoto K, Koto M, Mitsuya M, Matsufuji N, Takahashi S, Yamada S. Jingu K, et al. Among authors: narazaki k. BMC Cancer. 2010 Apr 7;10:127. doi: 10.1186/1471-2407-10-127. BMC Cancer. 2010. PMID: 20374623 Free PMC article.
The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage.
Jingu K, Kaneta T, Nemoto K, Ichinose A, Oikawa M, Takai Y, Ogawa Y, Nakata E, Sakayauchi T, Takai K, Sugawara T, Narazaki K, Fukuda H, Takahashi S, Yamada S. Jingu K, et al. Among authors: narazaki k. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):845-51. doi: 10.1016/j.ijrobp.2006.06.007. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011456
54 results